Uncovering Rare Genetic Variants in Multi-Incident Families

Multiple sclerosis (MS) is a complex neurological disorder that involves autoimmunity and demyelination within the central nervous system (CNS). The genetic underpinnings of this disease have primarily been explored through genome-wide association studies (GWAS), which focus on common variants. However, the contribution of rare genetic variants to MS susceptibility remains underexplored. The study "Whole Exome Sequencing in Multi-Incident Families Identifies Novel Candidate Genes for Multiple Sclerosis", published in International Journal of Molecular Sciences (2022), shifts focus toward identifying rare variants through whole exome sequencing (WES) in families with multiple cases of MS.

Study Design: Families with Multi-Incident MS
The study analyzed nine multi-incident Dutch families, each with 2-4 affected members, using WES and co-segregation analyses. A total of 55 participants were involved, including 31 who underwent WES (26 with MS and 29 unaffected relatives). The aim was to identify rare exonic variants segregating with the disease. In total, 18 rare variants were selected from WES data and further analyzed.

Key Findings: Rare Variants in 12 Genes
Through their approach, the researchers identified 12 rare variants across 12 genes—MBP, PLK1, MECP2, MTMR7, TOX3, CPT1A, SORCS1, TRIM66, ITPR3, TTC28, CACNA1F, and PRAM1—which demonstrated acceptable co-segregation with MS in at least some families. These variants offer new insights into the mechanisms that may underlie MS pathogenesis, especially concerning demyelination, remyelination, and immune dysregulation. Of the 12 genes, MBP (myelin basic protein), MECP2, and CPT1A were previously implicated in MS, further supporting their relevance to disease susceptibility. The study also identified variants in genes such as SORCS1 and TOX3, which were previously associated with MS through common variants.

Mechanistic Insights: The Role of Demyelination and Immune Regulation
The identified genes and their encoded proteins are primarily involved in processes related to myelination and immune responses, both key pathological aspects of MS. For instance, MBP encodes a crucial structural component of the myelin sheath, and its alteration can compromise myelin integrity. Additionally, variants in genes like PLK1 and MECP2 point to regulatory pathways influencing both myelination and immune responses, such as the phosphorylation of myelin proteins and the regulation of neuroinflammation.

Interestingly, the study also highlights the role of fatty acid metabolism in MS pathogenesis. For example, CPT1A, a gene involved in fatty acid oxidation, has been shown to modulate MS susceptibility. The study references previous findings indicating that populations with rare protective variants in CPT1A (such as the Inuit) have a much lower incidence of MS, suggesting that disruptions in fatty acid metabolism may contribute to disease onset.

Implications for MS Research and Therapeutics
This study underscores the importance of rare genetic variants in understanding MS, complementing previous GWAS findings that have mainly focused on common variants. The molecular framework developed by the researchers offers a new perspective on the complex genetic architecture of MS, with implications for potential therapeutic strategies aimed at promoting remyelination and targeting immune dysregulation. For instance, targeting PLK1 or CPT1A might provide new avenues for drug development, particularly in enhancing remyelination processes or modulating metabolic pathways that influence disease progression.

Limitations and Future Directions
While the findings are promising, the small sample size of this family-based study limits its statistical power. Future research should aim to replicate these findings in larger cohorts and investigate the functional consequences of the identified variants in cellular or animal models. Moreover, the incomplete co-segregation of some variants suggests a potential oligogenic inheritance model for MS, where multiple rare variants, rather than a single mutation, may contribute to disease risk.

Conclusion
The discovery of rare variants in genes involved in demyelination and immune regulation opens new pathways for understanding MS pathogenesis. The study by Horjus et al. (2022) is a significant step toward unraveling the genetic complexity of MS, particularly the role of rare genetic variants in multi-incident families. These findings provide a foundation for further exploration of novel therapeutic targets that could enhance remyelination and potentially alter disease progression in MS patients.

This work exemplifies the ongoing shift in genetic research from common variants to rare ones, highlighting the unique contributions of familial studies in advancing our understanding of complex diseases like MS.

Reference:
Horjus, J., van Mourik-Banda, T., Heerings, M. A. P., Hakobjan, M., De Witte, W., Heersema, D. J., Jansen, A. J., Strijbis, E. M. M., de Jong, B. A., Slettenaar, A. E. J., Zeinstra, E. M. P. E., Hoogervorst, E. L. J., Franke, B., Kruijer, W., Jongen, P. J., Visser, L. J., & Poelmans, G. (2022). Whole Exome Sequencing in Multi-Incident Families Identifies Novel Candidate Genes for Multiple Sclerosis. International journal of molecular sciences, 23(19), 11461. https://doi.org/10.3390/ijms231911461